Ganga Pharmaceuticals Ltd IPO

0

The Company was originally incorporated in Mumbai as “Ganga Pharmaceuticals Private Limited” on 11th September, 1989 under the provisions of the Companies Act, 1956 vide certificate of incorporation issued by the Registrar of Companies, Mumbai (the “RoC”).The Company was converted in to a Public Limited Company and consequently the name was changed to “Ganga Pharmaceuticals Limited” vide fresh certificate of incorporation dated 19th September, 1994 issued by the RoC, Mumbai.

Company profile:

Ganga Pharmaceuticals Ltd was established as a producer of quality Bulk Ayurvedic Medicines in Mumbai. Apart from manufacturing, the company is also into marketing, distribution of Bulk Ayurvedic Medicines. Under the Management of Late Shri Brijmohan Sharma, the Company had created an exceptional market reputation not only in Mumbai but all over Maharashtra. Initially, the company was manufacturing the following proprietary products:

 1) Ampachan Vati;

 2) Khadira Vati;

 3) Nirmalaya churna

Company Promoters:

  1. BHARAT BRIJMOHAN SHARMA
  2. SRIJNA BHARAT SHARMA

Objects of the Issue:

The objects of the issue are to:

1.Enhance Company visibility, brand name for future growth opportunities;
2. Creating a public trading market for the Equity Shares of the Company by listing them on BSE;
3. General corporate expenses;
4. To meet the expenses of the Issue.

Issue Detail:

  1. Issue Open: Jan 21, 2016 – Feb 3, 2016
  2. Issue Type: Fixed Price Issue IPO
  3. Issue Size: 1,024,000 Equity Shares of Rs. 10
  4. Issue Size: Rs. 1.54 Crore
  5. Face Value: Rs. 10 Per Equity Share
  6. Issue Price: Rs. 15 Per Equity Share
  7. Market Lot: 8000 Shares
  8. Minimum Order Quantity: 8000 Shares
  9. Listing At: BSE SME

Issue Expenses:

Ganga Pharmaceuticals Ltd IPO

Company Contact Details:

1 – A, 802, N.G. Suncity Ph II,

Kandivali East, Mumbai 400101,

Maharashtra, India;

Tel. No.: +91 250 609 8333/444;

Fax No.: +91 250 2528602;

Email: ayurvedganga@gmail.com;

 Website: www.ayurvedganga.com

Contact Person: Mr. Bharat Sharma, Compliance Officer

Lead Manager:

FIRST OVERSEAS CAPITAL LIMITED 1-2,

Bhupen Chambers Dalal Street, Fort,

 Mumbai 400 001

Tel. No.: +91 224050 9999

Fax No.: +91 22 4050 9900

Email: mala@focl.in

Investor Grievance Email: investorcomplaints@focl.in

Website: www.focl.in

Contact Person: Ms. Mala Soneji

SEBI Registration No.: INM000003671

Registrar to the Issue:

KARVY COMPUTERSHARE PRIVATE LIMITED

Karvy Selenium Tower B, Plot 31-32,

Gachibowli, Financial District, Nanakramguda,

Hyderabad 500 032 India

Tel. No.: 1-800-3454001/ +91 40 6716 2222

Fax No.: +91 40 2343 1551

 E-mail: einward.ris@karvy.com

Investor Grievance Email: gangapharma.ipo@karvy.com

Website: www.karisma.karvy.com

Contact Person: Mr. M Murali Krishna

SEBI Registration No.: INR000000221

Share.

About Author

mm

Money Dial is your destination to gain knowledge and earn greater returns in the world of financial market. Through Money Dial, we aim to help you sail smooth in your finances, rise high on returns and invest on success with tips, advice and market gyaan. Whenever you need a little extra help, our team of financial experts is here to guide you through the complex financial world by simplifying it and providing expert solutions to your problems.

Leave A Reply